APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mycology Immunoassays Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mycology Immunoassays Testing Market Outlook and Growth Opportunities 2026

19 December 2025196 pages

Choose your research edition.

Industry ResearchMycology Immunoassays Testing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Mycology Immunoassays Testing Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Mycology Immunoassays Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mycology Immunoassays Testing Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Mycology Immunoassays Testing Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Mycology Immunoassays Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mycology Immunoassays Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mycology Immunoassays Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mycology Immunoassays Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mycology Immunoassays Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mycology Immunoassays Testing market include Abbott, Roche, CapitalBio Corporation, Autobio Diagnostics CO.,Ltd., Siemens, Ortho-Clinical Diagnostics, MiraVista Diagnostics, ELITechGroup and bioMérieux, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Mycology Immunoassays Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mycology Immunoassays Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mycology Immunoassays Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Mycology Immunoassays Testing market.

Mycology Immunoassays Testing Segment by Company

Abbott

Roche

CapitalBio Corporation

Autobio Diagnostics CO.,Ltd.

Siemens

Ortho-Clinical Diagnostics

MiraVista Diagnostics

ELITechGroup

bioMérieux

Beckman Coulter

Mycology Immunoassays Testing Segment by Type

ELISA

ELISPOT

Polymerase Chain Reaction (PCR)

Rapid Tests

Mycology Immunoassays Testing Segment by Application

Hospitals

Blood Banks

Others

Mycology Immunoassays Testing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Mycology Immunoassays Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Mycology Immunoassays Testing key companies, revenue, market share, and recent developments.

3. To split the Mycology Immunoassays Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Mycology Immunoassays Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mycology Immunoassays Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Mycology Immunoassays Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mycology Immunoassays Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mycology Immunoassays Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mycology Immunoassays Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mycology Immunoassays Testing industry.

Chapter 3: Detailed analysis of Mycology Immunoassays Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Mycology Immunoassays Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Mycology Immunoassays Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mycology Immunoassays Testing Industry Trends Table 2. Mycology Immunoassays Testing Industry Drivers Table 3. Mycology Immunoassays Testing Industry Opportunities and Challenges Table 4. Mycology Immunoassays Testing Industry Restraints Table 5. Global Mycology Immunoassays Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mycology Immunoassays Testing Revenue Share by Company (2021-2026) Table 7. Global Mycology Immunoassays Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Mycology Immunoassays Testing Key Company Manufacturing Base & Headquarters Table 9. Global Mycology Immunoassays Testing Company, Product Type & Application Table 10. Global Mycology Immunoassays Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Mycology Immunoassays Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of ELISA Table 15. Significant Companies of ELISPOT Table 16. Significant Companies of Polymerase Chain Reaction (PCR) Table 17. Significant Companies of Rapid Tests Table 18. Global Mycology Immunoassays Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Mycology Immunoassays Testing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Mycology Immunoassays Testing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Mycology Immunoassays Testing Sales Value Share by Type (2021-2026) Table 22. Global Mycology Immunoassays Testing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospitals Table 24. Significant Companies of Blood Banks Table 25. Significant Companies of Others Table 26. Global Mycology Immunoassays Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Mycology Immunoassays Testing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Mycology Immunoassays Testing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Mycology Immunoassays Testing Sales Value Share by Application (2021-2026) Table 30. Global Mycology Immunoassays Testing Sales Value Share by Application (2027-2032) Table 31. Global Mycology Immunoassays Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Mycology Immunoassays Testing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Mycology Immunoassays Testing Sales Value Share by Region (2021-2026) Table 34. Global Mycology Immunoassays Testing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Mycology Immunoassays Testing Sales Value Share by Region (2027-2032) Table 36. Global Mycology Immunoassays Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Mycology Immunoassays Testing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Mycology Immunoassays Testing Sales Value Market Share by Country (2021-2026) Table 39. Global Mycology Immunoassays Testing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Mycology Immunoassays Testing Sales Value Market Share by Country (2027-2032) Table 41. Abbott Company Information Table 42. Abbott Business Overview Table 43. Abbott Mycology Immunoassays Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Abbott Mycology Immunoassays Testing Product Portfolio Table 45. Abbott Recent Development Table 46. Roche Company Information Table 47. Roche Business Overview Table 48. Roche Mycology Immunoassays Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Roche Mycology Immunoassays Testing Product Portfolio Table 50. Roche Recent Development Table 51. CapitalBio Corporation Company Information Table 52. CapitalBio Corporation Business Overview Table 53. CapitalBio Corporation Mycology Immunoassays Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. CapitalBio Corporation Mycology Immunoassays Testing Product Portfolio Table 55. CapitalBio Corporation Recent Development Table 56. Autobio Diagnostics CO.,Ltd. Company Information Table 57. Autobio Diagnostics CO.,Ltd. Business Overview Table 58. Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Product Portfolio Table 60. Autobio Diagnostics CO.,Ltd. Recent Development Table 61. Siemens Company Information Table 62. Siemens Business Overview Table 63. Siemens Mycology Immunoassays Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Siemens Mycology Immunoassays Testing Product Portfolio Table 65. Siemens Recent Development Table 66. Ortho-Clinical Diagnostics Company Information Table 67. Ortho-Clinical Diagnostics Business Overview Table 68. Ortho-Clinical Diagnostics Mycology Immunoassays Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Ortho-Clinical Diagnostics Mycology Immunoassays Testing Product Portfolio Table 70. Ortho-Clinical Diagnostics Recent Development Table 71. MiraVista Diagnostics Company Information Table 72. MiraVista Diagnostics Business Overview Table 73. MiraVista Diagnostics Mycology Immunoassays Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. MiraVista Diagnostics Mycology Immunoassays Testing Product Portfolio Table 75. MiraVista Diagnostics Recent Development Table 76. ELITechGroup Company Information Table 77. ELITechGroup Business Overview Table 78. ELITechGroup Mycology Immunoassays Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. ELITechGroup Mycology Immunoassays Testing Product Portfolio Table 80. ELITechGroup Recent Development Table 81. bioMérieux Company Information Table 82. bioMérieux Business Overview Table 83. bioMérieux Mycology Immunoassays Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. bioMérieux Mycology Immunoassays Testing Product Portfolio Table 85. bioMérieux Recent Development Table 86. Beckman Coulter Company Information Table 87. Beckman Coulter Business Overview Table 88. Beckman Coulter Mycology Immunoassays Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Beckman Coulter Mycology Immunoassays Testing Product Portfolio Table 90. Beckman Coulter Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Mycology Immunoassays Testing Product Image Figure 2. Global Mycology Immunoassays Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mycology Immunoassays Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Mycology Immunoassays Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. ELISA Image Figure 8. ELISPOT Image Figure 9. Polymerase Chain Reaction (PCR) Image Figure 10. Rapid Tests Image Figure 11. Global Mycology Immunoassays Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Mycology Immunoassays Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Mycology Immunoassays Testing Sales Value Share by Type (2021-2032) Figure 14. Hospitals Image Figure 15. Blood Banks Image Figure 16. Others Image Figure 17. Global Mycology Immunoassays Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Mycology Immunoassays Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Mycology Immunoassays Testing Sales Value Share by Application (2021-2032) Figure 20. Global Mycology Immunoassays Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Mycology Immunoassays Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Mycology Immunoassays Testing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Mycology Immunoassays Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Mycology Immunoassays Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Mycology Immunoassays Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Mycology Immunoassays Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Mycology Immunoassays Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Mycology Immunoassays Testing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Mycology Immunoassays Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Mycology Immunoassays Testing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Mycology Immunoassays Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA
  • ELISPOT
  • Polymerase Chain Reaction (PCR)
  • Rapid Tests
Applications
  • Hospitals
  • Blood Banks
  • Others
Companies covered
  • Abbott
  • Roche
  • CapitalBio Corporation
  • Autobio Diagnostics CO.,Ltd.
  • Siemens
  • Ortho-Clinical Diagnostics
  • MiraVista Diagnostics
  • ELITechGroup
  • bioMérieux
  • Beckman Coulter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mycology Immunoassays Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mycology Immunoassays Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Mycology Immunoassays Testing Market Dynamics
  1. 2.1 Mycology Immunoassays Testing Industry Trends
  2. 2.2 Mycology Immunoassays Testing Industry Drivers
  3. 2.3 Mycology Immunoassays Testing Industry Opportunities and Challenges
  4. 2.4 Mycology Immunoassays Testing Industry Restraints
3 Mycology Immunoassays Testing Market by Company
  1. 3.1 Global Mycology Immunoassays Testing Company Revenue Ranking in 2025
  2. 3.2 Global Mycology Immunoassays Testing Revenue by Company (2021-2026)
  3. 3.3 Global Mycology Immunoassays Testing Company Ranking (2024-2026)
  4. 3.4 Global Mycology Immunoassays Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Mycology Immunoassays Testing Company Product Type and Application
  6. 3.6 Global Mycology Immunoassays Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Mycology Immunoassays Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Mycology Immunoassays Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Mycology Immunoassays Testing Market by Type
  1. 4.1 Mycology Immunoassays Testing Type Introduction
  2. 4.1.1 ELISA
  3. 4.1.2 ELISPOT
  4. 4.1.3 Polymerase Chain Reaction (PCR)
  5. 4.1.4 Rapid Tests
  6. 4.2 Global Mycology Immunoassays Testing Sales Value by Type
  7. 4.2.1 Global Mycology Immunoassays Testing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Mycology Immunoassays Testing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Mycology Immunoassays Testing Sales Value Share by Type (2021-2032)
5 Mycology Immunoassays Testing Market by Application
  1. 5.1 Mycology Immunoassays Testing Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Blood Banks
  4. 5.1.3 Others
  5. 5.2 Global Mycology Immunoassays Testing Sales Value by Application
  6. 5.2.1 Global Mycology Immunoassays Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mycology Immunoassays Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Mycology Immunoassays Testing Sales Value Share by Application (2021-2032)
6 Mycology Immunoassays Testing Regional Value Analysis
  1. 6.1 Global Mycology Immunoassays Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mycology Immunoassays Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Mycology Immunoassays Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Mycology Immunoassays Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mycology Immunoassays Testing Sales Value (2021-2032)
  7. 6.3.2 North America Mycology Immunoassays Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Mycology Immunoassays Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Mycology Immunoassays Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Mycology Immunoassays Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Mycology Immunoassays Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Mycology Immunoassays Testing Sales Value (2021-2032)
  16. 6.6.2 South America Mycology Immunoassays Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Mycology Immunoassays Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Mycology Immunoassays Testing Sales Value Share by Country, 2025 VS 2032
7 Mycology Immunoassays Testing Country-level Value Analysis
  1. 7.1 Global Mycology Immunoassays Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mycology Immunoassays Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Mycology Immunoassays Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Mycology Immunoassays Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Mycology Immunoassays Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Mycology Immunoassays Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Mycology Immunoassays Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Mycology Immunoassays Testing Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Mycology Immunoassays Testing Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 CapitalBio Corporation
  14. 8.3.1 CapitalBio Corporation Company Information
  15. 8.3.2 CapitalBio Corporation Business Overview
  16. 8.3.3 CapitalBio Corporation Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CapitalBio Corporation Mycology Immunoassays Testing Product Portfolio
  18. 8.3.5 CapitalBio Corporation Recent Developments
  19. 8.4 Autobio Diagnostics CO.,Ltd.
  20. 8.4.1 Autobio Diagnostics CO.,Ltd. Company Information
  21. 8.4.2 Autobio Diagnostics CO.,Ltd. Business Overview
  22. 8.4.3 Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Product Portfolio
  24. 8.4.5 Autobio Diagnostics CO.,Ltd. Recent Developments
  25. 8.5 Siemens
  26. 8.5.1 Siemens Company Information
  27. 8.5.2 Siemens Business Overview
  28. 8.5.3 Siemens Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Mycology Immunoassays Testing Product Portfolio
  30. 8.5.5 Siemens Recent Developments
  31. 8.6 Ortho-Clinical Diagnostics
  32. 8.6.1 Ortho-Clinical Diagnostics Company Information
  33. 8.6.2 Ortho-Clinical Diagnostics Business Overview
  34. 8.6.3 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Product Portfolio
  36. 8.6.5 Ortho-Clinical Diagnostics Recent Developments
  37. 8.7 MiraVista Diagnostics
  38. 8.7.1 MiraVista Diagnostics Company Information
  39. 8.7.2 MiraVista Diagnostics Business Overview
  40. 8.7.3 MiraVista Diagnostics Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MiraVista Diagnostics Mycology Immunoassays Testing Product Portfolio
  42. 8.7.5 MiraVista Diagnostics Recent Developments
  43. 8.8 ELITechGroup
  44. 8.8.1 ELITechGroup Company Information
  45. 8.8.2 ELITechGroup Business Overview
  46. 8.8.3 ELITechGroup Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ELITechGroup Mycology Immunoassays Testing Product Portfolio
  48. 8.8.5 ELITechGroup Recent Developments
  49. 8.9 bioMérieux
  50. 8.9.1 bioMérieux Company Information
  51. 8.9.2 bioMérieux Business Overview
  52. 8.9.3 bioMérieux Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 bioMérieux Mycology Immunoassays Testing Product Portfolio
  54. 8.9.5 bioMérieux Recent Developments
  55. 8.10 Beckman Coulter
  56. 8.10.1 Beckman Coulter Company Information
  57. 8.10.2 Beckman Coulter Business Overview
  58. 8.10.3 Beckman Coulter Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beckman Coulter Mycology Immunoassays Testing Product Portfolio
  60. 8.10.5 Beckman Coulter Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst